Abbott LaboratoriesvsUtah Medical Products

ABT and UTMD stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$104.48

Value $182B

-0.22%
ABT's page

UTMD

Utah Medical Products, Inc.

$72.24

Value $230M

+0.31%
UTMD's page

Abbott Laboratories (ABT) has a market value of $182B and Utah Medical Products (UTMD) $230M. Over the last year, with dividends, ABT moved -17.7% and UTMD +34.0%. The P/E is 38.6 for ABT and 21.6 for UTMD. Dividend yield: ABT 2.41%, UTMD 1.72%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$182B

    UTMD$230M

    ABT is 789 times UTMD

  • Revenue, 12 months

    ABT$48.2B

    UTMD$35M

    ABT is 1,381 times UTMD

  • Net income, 12 months

    ABT$4.7B

    UTMD$11M

    ABT is 442 times UTMD

  • Operating margin

    ABT13.8%

    UTMD29.9%

    16.1 points apart

  • ROIC

    ABT6.3%

    UTMD7.1%

    0.8 points apart

  • P/E

    ABT38.6

    UTMD21.6

    ABT is 1.8 times UTMD

  • Dividend yield

    ABT2.4%

    UTMD1.7%

    0.7 points apart

  • 5-year return

    ABT-10.3%

    UTMD-28.0%

    17.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-10.3%

UTMD-28.0%

608010020222023202420252026
Returns by period
PeriodABTWith dividendsUTMDWith dividends
1 year since November 17, 2025-17.7%Price -19.6%+34.0%Price +31.5%
3 years since November 17, 2023+11.8%+3.8% a yearPrice +5.0%-9.0%-3.1% a yearPrice -14.0%
5 years since November 17, 2021-10.3%-2.1% a yearPrice -18.8%-28.0%-6.4% a yearPrice -34.7%
10 years since November 18, 2016+216.4%+12.2% a yearPrice +162.2%+28.4%+2.5% a yearPrice +9.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesUTMDUtah Medical Products

Valuation

ABTUTMD
Valuation
Price$104.48$72.24
Market value$182B$230M
Enterprise value (EV)$208B$145M
P/E38.621.6
P/E, 5-year median33.718.4
P/B3.61.9
EV/EBIT31.413.9
Free cash flow yield3.7%4.7%

Results and growth

ABTUTMD
Results and growth
Revenue, 12 months$48.2B$35M
Net income, 12 months$4.7B$11M
Free cash flow, 12 months$6.8B$11M
Earnings per share, 12 months$2.69$3.34
Revenue growth, year on year5.7%-5.8%
Revenue growth a year, past+5.1%over 5 years-1.8%over 5 years
EPS growth a year, past+8.3%over 5 years+3.4%over 5 years

Margins and returns on capital

ABTUTMD
Margins and returns on capital
Gross margin56.9%57.7%
Operating margin13.8%29.9%
Net margin9.8%30.5%
ROIC6.3%7.1%
ROE9.1%8.8%

Balance sheet

ABTUTMD
Balance sheet
Cash$4.3B$85M
Total debt$31.2B$180.0K
Net debt / EBITDA3.3-7.5
Interest cover6.7×–

Dividends and buybacks

ABTUTMD
Dividends and buybacks
Dividend yield2.4%1.7%
Dividend per share, 12 months$2.52$1.24
Dividend growth a year, past+10.4%over 5 years+1.9%over 5 years
Buyback yield0.5%3.6%
Shareholder yield2.9%5.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or UTMD

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or Utah Medical Products?

By market value, Abbott Laboratories ($182B) is about 789.1 times Utah Medical Products ($230M), at today's prices.

How did ABT and UTMD stock do over the last 10 years?

Since November 18, 2016, ABT's price moved +162.2% and UTMD's +9.2%. With dividends: ABT +216.4% (+12.2% a year), UTMD +28.4% (+2.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or UTMD?

The dividend yield at today's price is 2.41% for Abbott Laboratories and 1.72% for Utah Medical Products. Over the last twelve months they paid $2.52 and $1.24 per share.

What is the P/E of ABT and UTMD?

At today's price, the P/E is 38.6 for ABT and 21.6 for UTMD. The median of the last five years was 33.7 and 18.4, which shows where each stands against its own past.

Which has the higher profit margins, Abbott Laboratories or Utah Medical Products?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 30.5% for Utah Medical Products, and the operating margin 13.8% and 29.9%. Revenue was $48.2B and $35M.

Which is the better investment, Abbott Laboratories or Utah Medical Products?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.